Evolus, Inc. (EOLS)
NASDAQ: EOLS · Real-Time Price · USD
10.37
-0.42 (-3.89%)
Apr 21, 2025, 4:00 PM EDT - Market closed
Evolus Employees
Evolus had 332 employees as of December 31, 2024. The number of employees increased by 59 or 21.61% compared to the previous year.
Employees
332
Change (1Y)
59
Growth (1Y)
21.61%
Revenue / Employee
$802,030
Profits / Employee
-$151,867
Market Cap
660.03M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
UnitedHealth Group | 400,000 |
Johnson & Johnson | 138,100 |
Thermo Fisher Scientific | 125,000 |
Abbott Laboratories | 114,000 |
AstraZeneca | 92,900 |
Novartis AG | 75,883 |
EOLS News
- 3 days ago - Evolus Reports Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) - Business Wire
- 6 days ago - Evolus Announces Commercial Launch of Evolysse™ - Business Wire
- 7 days ago - Evolus Launches “Drop the F Word” Campaign in Advance of the Commercial Launch of Evolysse™ Injectable Hyaluronic Acid Gels - Business Wire
- 4 weeks ago - Evolus to Participate in The Needham 24th Annual Virtual Healthcare Conference - Business Wire
- 6 weeks ago - Evolus, Inc. (EOLS) Q4 2024 Earnings Call Transcript - Seeking Alpha
- 6 weeks ago - Evolus posts quarterly profit on strong sales of cosmetic injection - Reuters
- 6 weeks ago - Evolus Reports Record Fourth Quarter and Full-Year 2024 Financial Results; Reaffirms 2025 Guidance - Business Wire
- 7 weeks ago - Evolus to Participate in Fireside Chats and One-on-One Meetings at Upcoming Investor Conferences - Business Wire